USC researchers developed a technique that uses focused ultrasound to temporarily “light up” solid tumors, giving cancer-fighting immune cells a target they can finally recognize. For more than a decade, CAR-T cell …
In a landmark moment for both the treatment of heart disease and philanthropic support, The Marcus Foundation has awarded the head of USC Stem Cell Center, Chuck Murry, MD, PhD, $28.7 million …
In animal models, researchers from the Keck School of Medicine of USC found that targeting the thymus can reduce age-related inflammation and improve cancer outcomes. Chronic, low-grade inflammation in the body—a phenomenon …
USC researchers have developed a new “black box” tool to measure the softness of tumor cells, an insight that could be crucial for more effective cancer treatment. Researchers at the USC Viterbi …
A.P. Giannini, the founder of Bank of America, established the A.P. Giannini Foundation in 1945 to bring to fruition his long-held dream to promote the study and treatment of human diseases. Since …
Mapping the human kidney, researchers discovered an unrecognized developmental axis and engineered “synthetic organizer” cells to recreate key developmental signals, producing improved, reproducible lab-grown organoids for studying disease and therapies. In a …
AO Technologies, founded by USC researchers John Oghalai and Brian Applegate, has secured an ARPA-H small business award to develop a cochleoscope for clinical imaging of the inner ear. USC researchers John …
Researchers develop a way to grow and genetically engineer the progenitor cells that give rise to macrophages, a type of first-responder immune cell that shows promise for developing immunotherapies for cancers and …
All PhD students who are conducting research related to developmental biology, stem cell biology, and/or regenerative medicine are encouraged to apply for a training fellowship. We have two slots available for a …
USC Viterbi researchers have discovered that a naturally occurring nanoparticle found in urine shows early promise as a treatment, and potentially a prenatal intervention, for a rare disease that kills newborns and …